Belgium (BE)

Data-driven modelling of hydraulic-head time series: results and lessons learned from the 2022 Groundwater Time Series Modelling Challenge (2024) Collenteur RA, Haaf E, Bakker M, Liesch T, Wunsch A, Soonthornrangsan J, White J, et al. Journal article Interleukin-33-activated basophils promote asthma by regulating Th2 cell entry into lung tissue (2024) Schuijs MJ, Brenis Gomez CM, Bick F, Van Moorleghem J, Vanheerswynghels M, van Loo G, Beyaert R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction (2024) Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, et al. Journal article Compensating elastic faults in a torque-assisted knee exoskeleton: functional evaluation and user perception study (2024) Velasco Guillen RJ, Bliek A, Font-Llagunes JM, Vanderborght B, Beckerle P Journal article Tailoring the Use of Central Pancreatectomy Through Prediction Models for Major Morbidity and Postoperative Diabetes: International Retrospective Multicenter Study (2024) Van Bodegraven EA, Lof S, Jones L, Aussilhou B, Yong G, Jishu W, Klotz R, et al. Journal article Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors (2024) Willim J, Woike D, Greene D, Das S, Pfeifer K, Yuan W, Lindsey A, et al. Journal article Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease (2024) Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching P, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article